Table 2.
Genotypes | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ID | Age | Country of Birth | Monther Tongue | Cytology | 16 | 18 | 31 | 52 | 58 | 68 | |
Apatou (27 seqs) | CAP31 | 34 | Suriname | Bushinengue | ⚫ | ||||||
CAP41 | 37 | Suriname | Bushinengue | ⚫ | |||||||
CAP11 | 46 | Suriname | Bushinengue | HSIL | ⚫ | ||||||
CAP87 | 29 | Suriname | Bushinengue | ⚫ | ⚫ | ||||||
CAP88 | 50 | French Guiana | Bushinengue | ⚫ | |||||||
CAP100 | 26 | French Guiana | Bushinengue | LSIL | ⚫ | ||||||
CAP46 | 20 | French Guiana | Bushinengue | ASCUS | ⚫ | ⚫ | ⚫ | ||||
CAP10 | 49 | Suriname | Bushinengue | ⚫ | |||||||
CAP47 | 55 | Suriname | Bushinengue | HSIL & GA | ⚫ | ⚫ | |||||
CAP58 | 60 | French Guiana | Bushinengue | ⚫ | |||||||
CAP78 | 52 | French Guiana | Bushinengue | ⚫ | |||||||
CAP96 | 22 | French Guiana | Bushinengue | ⚫ | |||||||
CAP113 | 26 | French Guiana | Bushinengue | ⚫ | |||||||
CAP63 | 38 | French Guiana | Bushinengue | ⚫ | |||||||
CAP110 | 58 | Suriname | Bushinengue | ⚫ | |||||||
CAP57 | 22 | French Guiana | Bushinengue | ||||||||
CAP16 | 51 | Suriname | Bushinengue | ⚫ | |||||||
CAP27 | 64 | French Guiana | Bushinengue | ⚫ | |||||||
CAP42 | 54 | French Guiana | Bushinengue | ⚫ | |||||||
CAP59 | 60 | French Guiana | Bushinengue | ⚫ | |||||||
CAP61 | 48 | French Guiana | Bushinengue | ⚫ | |||||||
CAP64 | 39 | Suriname | Bushinengue | ⚫ | |||||||
CAP101 | 26 | Suriname | Bushinengue | ⚫ | |||||||
CAP108 | 22 | French Guiana | Bushinengue | ASCUS | ⚫ | ||||||
Grand Santi (8 seqs) | CGS04 | 37 | Suriname | Bushinengue | ⚫ | ||||||
CGS57 | 23 | French Guiana | Bushinengue | ⚫ | |||||||
CGS64 | 34 | French Guiana | Bushinengue | ⚫ | |||||||
CGS26 | 24 | Suriname | Bushinengue | ⚫ | |||||||
CGS31 | 56 | Suriname | Bushinengue | ⚫ | |||||||
CGS14 | 26 | Suriname | Bushinengue | ASCUS | ⚫ | ||||||
CGS69 | 43 | Suriname | Bushinengue | ASC-H | ⚫ | ||||||
CGS47 | 28 | Suriname | Bushinengue | HSIL | ⚫ | ||||||
Papaïchton (19 seqs) | CPA25 | 38 | French Guiana | Amerindian | ⚫ | ||||||
CPA79 | 28 | Brazil | Portuguese | ASCUS | ⚫ | ||||||
CPA45 | 55 | French Guiana | Bushinengue | ⚫ | |||||||
CPA52 | 26 | Dominican Rep. | Spanish | ASCUS | ⚫ | ||||||
CPA69 | 45 | French Guiana | Bushinengue | ⚫ | |||||||
CPA80 | 50 | French Guiana | Bushinengue | ⚫ | ⚫ | ||||||
CPA63 | 39 | Dominican Rep. | Spanish | LSIL | ⚫ | ||||||
CPA73 | 47 | Suriname | Dutch | ⚫ | ⚫ | ||||||
CPA19 | 44 | French Guiana | Bushinengue | ⚫ | |||||||
CPA46 | 58 | French Guiana | Bushinengue | ASCUS | ⚫ | ||||||
CPA08 | 42 | French Guiana | Bushinengue | ⚫ | |||||||
CPA18 | 40 | French Guiana | Bushinengue | ⚫ | |||||||
CPA21 | 30 | French Guiana | Bushinengue | ⚫ | |||||||
CPA56 | 61 | Suriname | Bushinengue | ⚫ | |||||||
CPA62 | 37 | French Guiana | Bushinengue | ⚫ | |||||||
CPA65 | 49 | Suriname | Bushinengue | ⚫ | |||||||
CPA72 | 64 | French Guiana | Bushinengue | ⚫ | |||||||
CPA01 | 33 | French Guiana | Bushinengue | ||||||||
Maripasoula (8 seqs) | CMA04 | 26 | Brazil | Portuguese | ASC-H | ⚫ | ⚫ | ⚫ | |||
CMA10 | 29 | Brazil | Portuguese | ⚫ | |||||||
CMA52 | 44 | Brazil | Portuguese | ASC-H | |||||||
CMA06 | 23 | Brazil | Portuguese | ⚫ | |||||||
CMA28 | 29 | French Guiana | Guianese Creole | ⚫ | |||||||
CMA33 | 32 | Guyana | English | LSIL | ⚫ | ||||||
CMA37 | 39 | Brazil | Portuguese | ASC-H | ⚫ | ||||||
Antecum Pata (3 seqs) | PAN07 | 55 | Brazil | Amerindian | LSIL | ⚫ | |||||
PAN12 | 64 | French Guiana | Amerindian | ⚫ | |||||||
CAN34 | 35 | French Guiana | Amerindian | ⚫ | |||||||
Twenke-Taluen
(2 seqs) |
PTW01 | 30 | Suriname | Amerindian | HSIL | ⚫ | |||||
CTW27 | 29 | Suriname | Amerindian | ||||||||
PTW03 | 40 | Suriname | Amerindian | ⚫ | |||||||
Total/genotype | 11 | 8 | 10 | 13 | 7 | 18 |
The number of sequences obtained for each village is indicated below the name of the villages. The four isolates from which no amplification product has been obtained are identified in light-grey. In the “Cytology” column, only isolates with an abnormal cytology are indicated. ASCUS stands for Atypical Squamous Cells of Unknown Significance; LSIL for Low grade Squamous Intraepithelial Lesion; ASC-H for Atypical Squamous Cell evocating High grade lesion; HSIL for High grade Squamous Intraepithelial Lesion and GA for Glandular Anomaly. The dots represent, for each sample, the different genotypes for which sequences have been obtained. The black squares represent the expected genotypes based on the Greiner Bio-One screening that have not been amplified. At the bottom of the table is indicated the total number of sequences obtained per genotype.